Vanguard Group Inc X Biotech Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in X Biotech Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 945,405 shares of XBIT stock, worth $2.49 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
945,405
Previous 1,062,772
11.04%
Holding current value
$2.49 Million
Previous $3.44 Million
18.47%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding XBIT
# of Institutions
53Shares Held
4.45MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.13MShares$2.98 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny551KShares$1.45 Million0.0% of portfolio
-
Credit Suisse Ag Zurich, V8248KShares$652,9500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA221KShares$580,3850.0% of portfolio
-
Rbf Capital, LLC San Francisco, CA200KShares$526,0000.03% of portfolio
About XBiotech Inc.
- Ticker XBIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,439,300
- Market Cap $80.1M
- Description
- XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...